The mean serum level of IL-1β was significantly higher among SLE patients with active disease (13.21 ± 10.76 pg/mL) as compared to those with inactive disease (6.23 ± 3.27 pg/mL, P = 0.0002) (Figure 1(c)). This evidence concerns the gene IL1B and glycogen storage disease VI.